Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Bronchoscopy Market

ID: MRFR/HC/9988-HCR
150 Pages
Rahul Gotadki
Last Updated: April 24, 2026

Bronchoscopy Market Size, Growth Research Report By Product (Endoscope, Visualization & Documentation Systems, Accessories, and Other), by Usability (Disposable Equipment and Reusable Equipment) by Application (Bronchial Diagnosis and Bronchial Treatment) by End User (Hospitals & Clinics, Ambulatory Surgery Centers, Others), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Competitor Industry Analysis and Trends Forecast Till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Bronchoscopy Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Bronchoscopy Market Summary

According to Market Research Future Reports analysis, the Bronchoscopy Market size was valued at USD 2.894 Billion in 2024. The market is projected to grow from USD 3.114 Billion in 2025 to USD 6.479 Billion by 2035, registering a CAGR of 7.6% during the forecast 2025–2035. North America led the market with 45% share, generating around USD 1.3 billion in revenue.
 
Rising global burden of respiratory diseases, coupled with increasing adoption of minimally invasive diagnostic procedures and advanced imaging technologies, is driving market growth. Growing awareness of early lung disease detection further accelerates demand for efficient, patient-centric diagnostic solutions worldwide.
 

  • According to the World Health Organization, chronic respiratory diseases caused over 3.9 million deaths annually, while the Institute for Health Metrics and Evaluation reports lung cancer among top mortality causes, reinforcing demand for early bronchoscopy-based diagnosis globally.

Key Market Trends & Highlights

The Bronchoscopy Market is experiencing robust growth driven by technological advancements and increasing demand for early diagnosis.

  • North America dominates with 45% share in 2024, supported by advanced healthcare infrastructure and high adoption of innovative bronchoscopy technologies.
  • Europe holds 30% share, generating approximately USD 0.87 billion in 2024, driven by strong screening programs and healthcare investments.
  • Rising respiratory disease burden, with over 3.9 million annual deaths globally, significantly drives bronchoscopy demand for early diagnosis.
  • Technological advancements in imaging and minimally invasive tools are accelerating adoption, improving diagnostic precision and procedural efficiency worldwide.

Market Size & Forecast

2024 Market Size 2.894 (USD Billion)
2035 Market Size 6.479 (USD Billion)
CAGR (2025 - 2035) 7.6%

Major Players

Companies such as Medtronic (US), Boston Scientific (US), Olympus Corporation (JP), Karl Storz (DE), Fujifilm Holdings Corporation (JP), Conmed Corporation (US), Hoya Corporation (JP), Ambu A/S (DK) are some of the major participants in the global market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Bronchoscopy Market Trends

The Bronchoscopy Market is currently experiencing a notable evolution, driven by advancements in technology and an increasing prevalence of respiratory diseases. The integration of innovative imaging techniques, including developments related to the electromagnetic navigation market, and minimally invasive procedures appears to enhance diagnostic accuracy and patient outcomes.

Furthermore, the growing awareness regarding early detection of lung conditions is likely to propel demand for bronchoscopy procedures. As healthcare systems worldwide prioritize patient-centered care, the Bronchoscopy Market is poised for substantial growth, reflecting a shift towards more efficient and effective treatment modalities within the broader flexible bronchoscopy market.

In addition, the market seems to be influenced by the rising adoption of telemedicine and remote monitoring solutions. These developments may facilitate access to bronchoscopy services, particularly in underserved regions. Moreover, the ongoing research and development efforts aimed at improving bronchoscopy instruments and techniques suggest a commitment to enhancing procedural safety and efficacy. Overall, the Bronchoscopy Market is on a trajectory of transformation, characterized by technological advancements and a focus on improving patient care across the medical market.

Technological Advancements

The Bronchoscopy Market is witnessing a surge in technological innovations, particularly in imaging and instrumentation. Enhanced visualization techniques, such as high-definition cameras and advanced imaging modalities, are likely to improve diagnostic capabilities, contributing to innovations seen across the ent and bronchoscopy devices market.

  • Advancements in imaging and bronchoscopy technologies are supported by rising investments in healthcare innovation. The Centers for Disease Control and Prevention highlights increasing adoption of advanced diagnostic tools for respiratory diseases, with millions undergoing imaging-based screenings annually, improving early detection accuracy and procedural outcomes globally.

Increased Demand for Early Diagnosis

There appears to be a growing emphasis on early diagnosis of respiratory diseases, which is driving the demand for bronchoscopy procedures. As healthcare providers recognize the importance of timely intervention, the Bronchoscopy Market is expected to expand, reflecting a proactive approach to managing lung health across the ent market.

  • Growing focus on early diagnosis is driven by increasing respiratory disease burden. The European Centre for Disease Prevention and Control reports lung cancer as one of the leading causes of cancer deaths in Europe, emphasizing early detection programs, which significantly boost demand for bronchoscopy procedures across screening and diagnostic pathways.

Shift Towards Minimally Invasive Techniques

The trend towards minimally invasive procedures is becoming increasingly prominent within the Bronchoscopy Market. Patients and healthcare professionals alike seem to favor techniques that reduce recovery time and minimize complications. This shift may lead to a broader acceptance of bronchoscopy as a preferred method for diagnosing and treating respiratory conditions, particularly within the flexible market.

  • Preference for minimally invasive procedures is increasing due to better patient outcomes and reduced recovery time. The Pan American Health Organization notes growing adoption of minimally invasive interventions across Latin America, improving treatment access and efficiency, thereby supporting increased utilization of bronchoscopy techniques in respiratory care.

Bronchoscopy Market Drivers

Growing Awareness and Education

The rising awareness regarding the importance of early diagnosis and treatment of respiratory diseases is significantly influencing the Bronchoscopy Market. Educational initiatives aimed at both healthcare professionals and patients are fostering a better understanding of bronchoscopy procedures and their benefits.
 
This increased awareness is likely to lead to higher patient referrals for bronchoscopy, as individuals become more proactive about their respiratory health. Furthermore, healthcare providers are investing in training programs to enhance the skills of practitioners in performing bronchoscopy, which may contribute to improved procedural outcomes. As a result, the market is expected to expand as more patients seek these essential diagnostic services.

Increase in Geriatric Population

The demographic shift towards an aging population is a significant factor driving the Bronchoscopy Market. Older adults are more susceptible to respiratory diseases due to age-related physiological changes and comorbidities. As the global population ages, the demand for bronchoscopy procedures is likely to increase, as these individuals often require advanced diagnostic and therapeutic interventions for respiratory conditions.
 
Data suggests that the geriatric population is projected to grow substantially in the coming years, further emphasizing the need for effective healthcare solutions. Consequently, the market is expected to benefit from this demographic trend, as healthcare systems adapt to meet the needs of an older population.

Rising Incidence of Respiratory Diseases

The increasing prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer, is a primary driver of the Bronchoscopy Market. According to recent data, respiratory diseases account for a significant portion of global morbidity and mortality. The World Health Organization indicates that COPD alone affects millions worldwide, necessitating advanced diagnostic and therapeutic interventions.
 
As healthcare systems strive to address this growing burden, the demand for bronchoscopy procedures is likely to rise. This trend is further supported by the development of innovative bronchoscopy technologies that enhance diagnostic accuracy and treatment efficacy. Consequently, the market is poised for substantial growth as healthcare providers seek effective solutions to manage and treat respiratory conditions.

Technological Innovations in Bronchoscopy

Technological advancements play a crucial role in shaping the Bronchoscopy Market. Innovations such as robotic-assisted bronchoscopy and advanced imaging techniques have revolutionized the field, allowing for more precise and less invasive procedures.
 
For instance, the introduction of electromagnetic navigation bronchoscopy has improved the ability to access peripheral lung lesions, which was previously challenging. These advancements not only enhance patient outcomes but also increase the efficiency of procedures, thereby attracting more healthcare facilities to adopt bronchoscopy technologies. As a result, the market is experiencing a surge in demand for these cutting-edge tools, which are expected to drive growth in the market over the coming years.

Regulatory Support and Reimbursement Policies

Supportive regulatory frameworks and favorable reimbursement policies are essential drivers of the Bronchoscopy Market. Governments and health organizations are increasingly recognizing the value of bronchoscopy in diagnosing and treating respiratory diseases, leading to improved reimbursement rates for these procedures.
 
This financial support encourages healthcare providers to invest in bronchoscopy technologies and expand their service offerings. Additionally, regulatory bodies are streamlining approval processes for new bronchoscopy devices, facilitating quicker access to innovative solutions. As a result, the market is likely to experience growth as healthcare providers are incentivized to adopt and implement advanced bronchoscopy techniques.

Market Segment Insights

By Product: Endoscope (Largest) vs. Accessories (Fastest-Growing)

In the Bronchoscopy Market, the endoscope segment accounts for the largest 62% share, driven by its critical role in enabling both diagnostic and therapeutic procedures. Coupled with the increasing prevalence of respiratory disorders, this segment benefits from advancements in technology, enhancing the efficacy and safety of bronchoscopic procedures. Accessories follow closely, comprising a significant portion of the market due to their essential role in facilitating various applications across bronchoscopy applications. The diverse range of accessories also caters to the growing customization needs in clinical settings, ensuring optimal performance for clinicians and improved outcomes for patients, supporting broader market segmentation bronchoscopy analysis.

Endoscope (Dominant) vs. Accessories (Emerging)

The Endoscope segment, regarded as the dominant force in the Bronchoscopy Market, is crucial for providing direct visualization of the respiratory tract. Modern endoscopes incorporate state-of-the-art imaging technologies, boosting their utility in diagnostics and interventions. Meanwhile, the Accessories segment is characterized by rapid growth as it increasingly adopts advanced materials and designs to support procedural efficiency and patient safety. This surge can be attributed to innovations aimed at enhancing equipment compatibility and user experience. Furthermore, the rising demand for personalized treatment options is driving accessory manufacturers to expand their product lines, positioning them as an emerging force to complement the continued dominance of endoscopes in the bronchoscopy landscape, including innovations relevant to the ent bronchoscopy devices market.

By Usability: Disposable Equipment (Largest) vs. Reusable Equipment (Fastest-Growing)

In the bronchoscopy market, the usability segment reflects a clear split between disposable and reusable equipment, with disposable devices accounting for a dominant 58% share, driven by their convenience and growing preference for single-use products in clinical settings. On the other hand, reusable equipment captures a smaller percentage but is gaining traction as healthcare facilities focus on sustainability and cost-effectiveness, leading to innovative developments in this category.

Usability: Disposable Equipment (Dominant) vs. Reusable Equipment (Emerging)

Disposable equipment has emerged as the dominant force in the bronchoscopy market, favored for its hygiene, ease of use, and compliance with infection control guidelines. As healthcare practices evolve, the demand for single-use bronchoscopes and related tools is on the rise, driven by heightened awareness of cross-contamination risks. Conversely, reusable equipment is positioned as the emerging option, appealing to healthcare facilities aiming to reduce waste and manage costs effectively. Innovation in reprocessing technologies and design improvements are enabling reusable devices to enhance their appeal, making them a viable alternative as healthcare providers balance operational efficiency with patient safety.

By Application: Bronchial Diagnosis (Largest) vs. Bronchial Treatment (Fastest-Growing)

In the Bronchoscopy Market, the application segment shows a significant distribution, with bronchial diagnosis accounting for the leading 64% share, driven by its essential role in detecting and evaluating respiratory conditions. This dominant position is attributed to its essential role in early detection of respiratory diseases, which is becoming increasingly important in healthcare. Meanwhile, Bronchial Treatment, while currently smaller in share, is rapidly gaining traction due to advancements in minimally invasive techniques and personalized medicine approaches, catering to diverse patient needs across emerging areas such as the fibrotic market.

Bronchial Diagnosis (Dominant) vs. Bronchial Treatment (Emerging)

Bronchial Diagnosis stands out as the dominant application in the Bronchoscopy Market, emphasizing its critical importance in diagnosing various respiratory conditions. It employs advanced imaging and diagnostic technologies, enabling healthcare professionals to identify issues such as tumors, infections, and chronic illnesses effectively. On the other hand, Bronchial Treatment is emerging as a vital segment, propelled by innovations in therapeutic techniques and drug delivery systems. As healthcare shifts towards targeted therapies, the Bronchial Treatment segment is set to expand its footprint, making it an essential area for future market growth.

By End User: Hospitals & Clinics (Largest) vs. Ambulatory Surgery Centers (Fastest-Growing)

In the bronchoscopy market, the end-user segment is dominated by hospitals and clinics, which account for the largest 68% market share, supported by their advanced infrastructure and comprehensive diagnostic capabilities. This segment benefits from the high volume of procedures performed in these settings as they are equipped with advanced technology and specialized healthcare professionals. Additionally, the accessibility of these facilities to a wide patient demographic contributes significantly to their commanding position in the market. On the other hand, ambulatory surgery centers are emerging as a notable player in the market. Their market share is rapidly increasing due to the rise in preference for outpatient procedures, enabling patients to receive care in a more cost-effective and convenient environment. The growth trends in the market for end-users show a clear shift towards ambulatory surgery centers, which are recognized for their efficiency and effectiveness in terms of patient throughput and recovery times. This is further driven by the increasing demand for minimally invasive procedures, which are mainly conducted in these centers. Hospitals and clinics must innovate and improve their services to compete effectively with the growing preference for ambulatory care. Furthermore, the rising patient awareness about surgical options and advancements in bronchoscopy technology are propelling both segments, but particularly favoring the agility and accessibility offered by ambulatory surgery centers.

Hospitals & Clinics (Dominant) vs. Ambulatory Surgery Centers (Emerging)

Hospitals and clinics represent the dominant segment in the bronchoscopy market, characterized by comprehensive care options and extensive surgical facilities. This segment benefits from wider patient access due to established trust and long-standing relationships with communities. Their ability to provide a full range of medical services enhances patient retention and encourages referrals. Conversely, ambulatory surgery centers are emerging as a pivotal segment, primarily because of their focus on patient-centered care and reduced wait times. These centers are designed for outpatient procedures, allowing for quicker recovery and diminished hospital stays, making them increasingly appealing. Technological advancements and a growing emphasis on non-invasive procedures within these centers support their rapid market growth, establishing them as formidable competitors to traditional hospitals and clinics.

Get more detailed insights about Bronchoscopy Market
Request Free Sample

Regional Insights

North America : Healthcare Innovation Leader

North America is the largest market for bronchoscopy, holding approximately 45% of the global share, driven by advanced healthcare infrastructure, increasing prevalence of respiratory diseases, and technological innovations, contributing significantly to the bronchoscopy market size. Regulatory support from agencies like the FDA has further catalyzed market growth, ensuring the availability of cutting-edge bronchoscopy devices and procedures.

The demand for minimally invasive procedures is also on the rise, contributing to market expansion. The United States leads the North American market, with significant contributions from Canada. Key players such as Medtronic, Boston Scientific, and Olympus Corporation dominate the competitive landscape, focusing on product innovation and strategic partnerships. The presence of well-established healthcare facilities and a growing emphasis on early diagnosis and treatment of respiratory conditions are pivotal in shaping the market dynamics in this region.

Europe : Emerging Market Dynamics

Europe Bronchoscopy Market accounted for 30% share in 2024, generating around USD 0.87 billion, making it the second-largest regional market, with strong development across the medical market. The region is witnessing growth driven by increasing awareness of respiratory diseases, advancements in medical technology, and supportive regulatory frameworks. The European Medicines Agency (EMA) has been instrumental in streamlining the approval processes for new bronchoscopy devices, enhancing market accessibility and innovation. Germany, France, and the UK are the leading countries in this market, with a strong presence of key players like Karl Storz and Fujifilm Holdings Corporation. The competitive landscape is characterized by a mix of established companies and emerging startups focusing on innovative bronchoscopy solutions. The growing demand for outpatient procedures and the integration of digital technologies in healthcare are also shaping the market's future.

Asia-Pacific : Rapidly Growing Market

Asia-Pacific is an emerging powerhouse in the bronchoscopy market, holding approximately 20% of the global share. The region is experiencing rapid growth due to rising healthcare expenditures, increasing prevalence of chronic respiratory diseases, and a growing geriatric population. Governments are investing in healthcare infrastructure, which is expected to further boost the demand for bronchoscopy procedures and devices in the coming years. China, Japan, and India are the leading countries in this market, with significant contributions from local and international players. Companies like Hoya Corporation and Ambu A/S are expanding their presence in the region, focusing on affordable and innovative bronchoscopy solutions. The competitive landscape is evolving, with an increasing number of partnerships and collaborations aimed at enhancing product offerings and market reach.

Middle East and Africa : Untapped Market Potential

The Middle East and Africa region is gradually emerging in the bronchoscopy market, currently holding about 5% of the global share. The growth is driven by increasing awareness of respiratory diseases, rising healthcare investments, and the need for advanced medical technologies. Governments are focusing on improving healthcare infrastructure, which is expected to enhance the accessibility of bronchoscopy procedures in the region. Countries like South Africa and the UAE are leading the market, with a growing number of healthcare facilities adopting advanced bronchoscopy technologies. The competitive landscape is characterized by a mix of local and international players, with companies looking to establish a foothold in this untapped market. The increasing prevalence of respiratory conditions is likely to drive demand for bronchoscopy solutions in the coming years.

Bronchoscopy Market Regional Image

Key Players and Competitive Insights

The Bronchoscopy Market is currently characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of respiratory diseases, reinforcing insights derived from bronchoscopy market research. Key players such as Medtronic (US), Boston Scientific (US), and Olympus Corporation (JP) are strategically positioned to leverage innovation and expand their market presence. Medtronic (US) focuses on enhancing its product portfolio through continuous innovation, while Boston Scientific (US) emphasizes strategic partnerships to bolster its technological capabilities.
 
Olympus Corporation (JP) is known for its commitment to research and development, which allows it to maintain a competitive edge in the market. Collectively, these strategies contribute to a robust competitive environment, fostering growth and innovation within the industry. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and enhance supply chain efficiency. This approach appears to be particularly relevant in the context of the Bronchoscopy Market, which is moderately fragmented, with several players vying for market share.
 
The collective influence of key players shapes the market structure, as they engage in strategic collaborations and optimize their operations to meet the evolving demands of healthcare providers. In August 2025, Medtronic (US) announced the launch of its latest bronchoscopy system, which integrates advanced imaging technology to improve diagnostic accuracy. This strategic move is significant as it not only enhances Medtronic's product offerings but also positions the company as a leader in innovation within the bronchoscopy space.
 
The introduction of this system is likely to attract healthcare providers seeking cutting-edge solutions for respiratory diagnostics. In September 2025, Boston Scientific (US) entered into a partnership with a leading telehealthprovider to enhance remote monitoring capabilities for patients undergoing bronchoscopy procedures. This collaboration is indicative of a broader trend towards digital health solutions, suggesting that Boston Scientific is keen on integrating technology to improve patient outcomes and streamline workflows.
 
Such initiatives may enhance the company's competitive positioning in an increasingly digital healthcare landscape. In July 2025, Olympus Corporation (JP) expanded its manufacturing capabilities in Europe to better serve the growing demand for bronchoscopy products. This expansion reflects Olympus's commitment to regional growth and its strategy to optimize supply chain logistics. By increasing its production capacity, Olympus is likely to enhance its responsiveness to market needs, thereby strengthening its competitive stance.
 
As of October 2025, the Bronchoscopy Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence. These trends are reshaping the competitive landscape, as companies increasingly focus on strategic alliances to enhance their technological capabilities. The shift from price-based competition to a focus on innovation and supply chain reliability is becoming evident, suggesting that future competitive differentiation will hinge on the ability to deliver advanced, reliable, and sustainable solutions.

Key Companies in the Bronchoscopy Market include

Industry Developments

  • Q2 2024: Olympus launches EVIS X1, its most advanced endoscopy system, in the United States Olympus announced the U.S. launch of its EVIS X1 endoscopy system, which includes advanced bronchoscopy capabilities designed to improve diagnostic and therapeutic procedures for respiratory diseases.
  • Q1 2024: Ambu receives FDA 510(k) clearance for Ambu® aScope™ 5 Broncho Ambu announced it received FDA 510(k) clearance for its aScope 5 Broncho, a single-use bronchoscope designed for advanced bronchoscopy procedures in the U.S. market.
  • Q2 2024: Boston Scientific launches EXALT Model B single-use bronchoscope in Europe Boston Scientific announced the commercial launch of its EXALT Model B single-use bronchoscope in select European markets, expanding its portfolio of disposable endoscopy solutions.
  • Q1 2024: Fujifilm launches new ELUXEO Ultra bronchoscopy system in Japan Fujifilm introduced the ELUXEO Ultra bronchoscopy system in Japan, featuring enhanced imaging technology for improved detection and diagnosis of pulmonary diseases.
  • Q2 2024: Medtronic acquires privately held bronchoscopy device maker InterVapor for $350 million Medtronic announced the acquisition of InterVapor, a company specializing in minimally invasive bronchoscopy devices for lung disease treatment, to strengthen its respiratory portfolio.
  • Q1 2024: Olympus and Veran Medical Technologies announce strategic partnership for advanced bronchoscopy navigation Olympus and Veran Medical Technologies entered a partnership to integrate Veran’s navigation technology with Olympus’ bronchoscopy systems, aiming to improve accuracy in lung cancer diagnosis.
  • Q2 2024: Ambu opens new manufacturing facility for single-use endoscopes in Mexico Ambu inaugurated a new manufacturing facility in Mexico to increase production capacity for its single-use bronchoscopes and meet growing global demand.
  • Q1 2024: Boston Scientific receives CE Mark for EXALT Model B single-use bronchoscope Boston Scientific announced it received CE Mark approval for its EXALT Model B single-use bronchoscope, allowing commercialization in the European Union.
  • Q2 2024: Fujifilm opens new R&D center for endoscopy innovation in Germany Fujifilm opened a new research and development center in Germany focused on advancing endoscopy and bronchoscopy technologies for the European market.
  • Q1 2024: Karl Storz appoints new CEO to drive digital transformation in endoscopy Karl Storz announced the appointment of a new CEO, emphasizing a strategic focus on digital innovation and expansion in the bronchoscopy and endoscopy sectors.
  • Q2 2024: Olympus receives FDA clearance for BF-UC190F endobronchial ultrasound bronchoscope Olympus announced it received FDA clearance for its BF-UC190F endobronchial ultrasound bronchoscope, expanding its portfolio of advanced diagnostic tools for lung cancer.
  • Q1 2024: Ambu secures contract to supply single-use bronchoscopes to major U.S. hospital network Ambu announced it secured a multi-year contract to supply its single-use bronchoscopes to a leading U.S. hospital network, supporting infection control and procedural efficiency.

Future Outlook

Bronchoscopy Market Future Outlook

The Bronchoscopy Market size is projected to reach USD 6.479 Billion by 2035, growing at a CAGR of 7.6%, driven by technological advancements, increasing respiratory diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Development of AI-driven diagnostic tools for enhanced accuracy Expansion of telemedicine platforms for remote bronchoscopic consultations Investment in minimally invasive bronchoscopic techniques for outpatient procedures

By 2035, the Bronchoscopy Market is expected to achieve substantial growth and innovation.

Market Segmentation

Bronchoscopy Market Product Outlook

  • Endoscope
  • Visualization & Documentation Systems
  • Accessories
  • Others

Bronchoscopy Market End User Outlook

  • Hospitals & Clinics
  • Ambulatory Surgery Centers
  • Others

Bronchoscopy Market Usability Outlook

  • Disposable Equipment
  • Reusable Equipment

Bronchoscopy Market Application Outlook

  • Bronchial Diagnosis
  • Bronchial Treatment

Report Scope

MARKET SIZE 2024 2.894(USD Billion)
MARKET SIZE 2025 3.114(USD Billion)
MARKET SIZE 2035 6.479(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.6% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Medtronic (US), Boston Scientific (US), Olympus Corporation (JP), Karl Storz (DE), Fujifilm Holdings Corporation (JP), Conmed Corporation (US), Hoya Corporation (JP), Ambu A/S (DK)
Segments Covered Product, Usability, Application, End User, Region
Key Market Opportunities Integration of advanced imaging technologies enhances diagnostic accuracy in the market.
Key Market Dynamics Technological advancements in bronchoscopy are driving enhanced diagnostic capabilities and improving patient outcomes.
Countries Covered North America, Europe, APAC, South America, MEA

Market Highlights

FAQs

What is the projected market valuation of the Bronchoscopy Market by 2035?

The market is projected to reach a valuation of 6.479 USD Billion by 2035.

What was the market valuation of the market in 2024?

In 2024, the market was valued at 2.894 USD Billion.

What is the expected CAGR for the Bronchoscopy Market during the forecast period 2025 - 2035?

The expected CAGR for the market during the forecast period 2025 - 2035 is 7.6%.

Which companies are considered key players in the market?

Key players in the market include Medtronic, Boston Scientific, Olympus Corporation, Karl Storz, Fujifilm Holdings Corporation, Conmed Corporation, Hoya Corporation, and Ambu A/S.

What are the main product segments in the Bronchoscopy Market?

The main product segments in the market include Endoscopes, Visualization & Documentation Systems, Accessories, and Others.

How did the valuation of disposable equipment compare to reusable equipment in 2024?

In 2024, the valuation for disposable equipment was 1.447 USD Billion, matching that of reusable equipment.

What is the projected valuation for bronchial diagnosis by 2035?

The projected valuation for bronchial diagnosis is expected to reach 3.295 USD Billion by 2035.

What end-user segments are included in the Bronchoscopy Market?

End-user segments in the market include Hospitals & Clinics, Ambulatory Surgery Centers, and Others.

What was the valuation of visualization and documentation systems in 2024?

In 2024, the valuation of visualization and documentation systems was 0.8 USD Billion.

What is the expected growth trend for the Bronchoscopy Market in the coming years?

The market is anticipated to experience robust growth, with a projected valuation increase to 6.479 USD Billion by 2035.
Author
Author
Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative healthcare organizations. Key sources included the US Food & Drug Administration (FDA) Center for Devices and Radiological Health, European Medicines Agency (EMA) Medical Devices Coordination Group, National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, World Health Organization (WHO) Global Health Observatory, American College of Chest Physicians (CHEST), American Thoracic Society (ATS), British Thoracic Society (BTS), European Respiratory Society (ERS), Japan Society for Respiratory Endoscopy, Society for Advanced Bronchoscopy, Agency for Healthcare Research and Quality (AHRQ), ECRI Institute, EU Eurostat Health Database, OECD Health Statistics, and national health ministry reports from key markets including China National Health Commission, India's Ministry of Health and Family Welfare, and Japan's Ministry of Health, Labour and Welfare. These sources were used to collect respiratory disease epidemiology data, medical device regulatory approval pathways, clinical safety and efficacy studies for bronchoscopic procedures, procedure volume statistics, hospital infrastructure data, and competitive landscape analysis for rigid bronchoscopes, flexible bronchoscopes, video bronchoscopes, EBUS systems, navigation bronchoscopy platforms, and associated accessories and consumables.

 

Primary Research

In order to gather both qualitative and quantitative insights, supply-side and demand-side stakeholders were interviewed during the primary research process. CEOs, VPs of Product Development, leaders of R&D, regulatory affairs directors, and commercial executives from makers of bronchoscopy devices, endoscope OEMs, and imaging technology suppliers were examples of supply-side sources. Interventional pulmonologists, thoracic surgeons, otolaryngologists, hospital procurement directors, administrators of ambulatory surgery centers, and heads of bronchoscopy units from cancer centers, pulmonary specialist clinics, and tertiary care hospitals were among the demand-side sources. Primary research verified product pipeline timelines for robotic bronchoscopy and AI-integrated platforms, validated market segmentation across product categories (endoscopes, visualization systems, accessories), usability preferences (disposable vs. reusable), clinical applications (bronchial diagnosis vs. treatment), and end-user settings. It also gathered information on clinical adoption patterns of advanced navigation systems, pricing strategies for capital equipment and consumables, and reimbursement dynamics for diagnostic vs. therapeutic bronchoscopy procedures.

Primary Respondent Breakdown:

By Designation: C-level Primaries (42%), Director Level (31%), Others (27%)

By Region: North America (38%), Europe (25%), Asia-Pacific (32%), Rest of World (5%)

 

Market Size Estimation

Global market valuation was derived through revenue mapping, installed base analysis, and procedure volume assessment. The methodology included:

Identification of 40+ key manufacturers and technology providers across North America, Europe, Asia-Pacific, and Latin America, including specialized bronchoscopy device makers and diversified endoscopy technology conglomerates

Product mapping across rigid bronchoscopes, flexible bronchoscopes (fiberoptic and video), single-use bronchoscopes, visualization & documentation systems (HD cameras, light sources, video processors), bronchial ultrasound systems (EBUS), electromagnetic navigation systems, and procedure-specific accessories (biopsy forceps, brushes, needles, retrieval baskets)

Analysis of reported and modeled annual revenues specific to bronchoscopy portfolios, including equipment sales, aftermarket services, and recurring consumables revenue

Coverage of manufacturers and key distributors representing 72-78% of global market share in 2024

Extrapolation using bottom-up (procedure volume × ASP by country, adjusted for reusable vs. disposable equipment mix) and top-down (manufacturer revenue validation, distributor margin analysis) approaches to derive segment-specific valuations for diagnostic bronchoscopy, therapeutic interventions, and robotic-assisted procedures

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓